You are here

Mechanisms of PSK Enhancement of Docetaxel in a Xenograft of Human Prostate Cancer



Study area


Principal investigator

Cynthia Wenner, PhD

Project period

2008 – 2011

The objective of this study is to better understand the mechanisms of polysaccharide krestin, an extract of mushroom Trametes versicolor, enhancement of docetaxel for the treatment of hormone refractory prostate cancer (HRPC) to lay the groundwork for a Phase I dose escalation trial in patients with HRPC.